Initial Public Offering. A biotechnology company, Keron Therapeutics, completed its IPO on April 8, 2020, and listed on the Mandau Karo wold 8 200,000 shares of stock to primary market investors at an IPO offer price of $18.00, with an underwriting discount of 6.5%. Secondary market investors, however, we paying $16.10 per share for Keros' 31,025,936 shares of stock outstanding. a. Calculate the total proceeds for Keros' IPO b. Calculate the dollar amount of the underwriting for for Keros' IPO. c. Calculate the net proceeds for Keros' IPO. d. Calculate market capitalization for Keros' outstanding stock. e. Calculate IPO underpricing for Keros' IPO. 1. Explain the IPO underpricing for Keros. a. The total proceeds for Keros' IPO is $0 (Round to the nearest dollar)